Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0000899243-22-016641 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-04 | 2022-05-02 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $259.16 | -320 | 41.9K | -0.8% | -$82.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-02 | S | D | 75 | $259.58 | 41,788 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $259.58 (range $259.24 to $260.07). |
| 2 | Common | Common Stock | 2022-05-02 | S | D | 23 | $260.44 | 41,765 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $260.44 (range $260.35 to $261.31). |
| 3 | Common | Common Stock | 2022-05-02 | S | D | 65 | $261.79 | 41,700 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $261.79 (range $261.39 to $262.23). |
| 4 | Common | Common Stock | 2022-05-02 | S | D | 4 | $264.37 | 41,696 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-02 | S | D | 20 | $255.47 | 41,996 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $255.47 (range $255.23 to $255.70). (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2022-05-02 | S | D | 90 | $257.49 | 41,906 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $257.49 (range $257.05 to $257.87). |
| 7 | Common | Common Stock | 2022-05-02 | S | D | 43 | $258.46 | 41,863 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $258.46 (range $258.11 to $258.93). |